246 related articles for article (PubMed ID: 23010958)
21. Fever after transcatheter arterial chemoembolization for hepatocellular carcinoma: incidence and risk factor analysis.
Li CP; Chao Y; Chen LT; Lee RC; Lee WP; Yuan JN; Yen SH; Lee SD
Scand J Gastroenterol; 2008 Aug; 43(8):992-9. PubMed ID: 19086281
[TBL] [Abstract][Full Text] [Related]
22. [Chemoembolization with Drug Eluting Beads (TACE DEB) in patients with primary unresectable hepatocellular carcinoma (HCC)].
Třeška V; Duras P; Mírka H; Skalický T; Vyčítal O; Brůha J; Opatrný J; Liška V; Sutnar A
Rozhl Chir; 2014 Feb; 93(2):63-9. PubMed ID: 24702289
[TBL] [Abstract][Full Text] [Related]
23. Effects of in-hospital exercise on sarcopenia in hepatoma patients who underwent transcatheter arterial chemoembolization.
Koya S; Kawaguchi T; Hashida R; Hirota K; Bekki M; Goto E; Yamada M; Sugimoto M; Hayashi S; Goshima N; Yoshiyama T; Otsuka T; Nozoe R; Nagamatsu A; Nakano D; Shirono T; Shimose S; Iwamoto H; Niizeki T; Matsuse H; Koga H; Miura H; Shiba N; Torimura T
J Gastroenterol Hepatol; 2019 Mar; 34(3):580-588. PubMed ID: 30402913
[TBL] [Abstract][Full Text] [Related]
24. Postintervention Interleukin-6 (IL-6) Level, Rather than the Pretreatment or Dynamic Changes of IL-6, as an Early Practical Marker of Tumor Response in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
Wu Y; Fan W; Xue M; Zhong B; Zhang S; Wang Y; Yao W; Zhao Y; Li J
Oncologist; 2019 Dec; 24(12):e1489-e1495. PubMed ID: 31249138
[TBL] [Abstract][Full Text] [Related]
25. Quality of life and survival analysis of patients undergoing transarterial chemoembolization for primary hepatic malignancies: a prospective cohort study.
Eltawil KM; Berry R; Abdolell M; Molinari M
HPB (Oxford); 2012 May; 14(5):341-50. PubMed ID: 22487072
[TBL] [Abstract][Full Text] [Related]
26. Risk of hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma: predictive value of the monoethylglycinexylidide test.
Huang YS; Chiang JH; Wu JC; Chang FY; Lee SD
Am J Gastroenterol; 2002 May; 97(5):1223-7. PubMed ID: 12014732
[TBL] [Abstract][Full Text] [Related]
27. Survival benefit of chemoembolization plus Iodine125 seed implantation in unresectable hepatitis B-related hepatocellular carcinoma with PVTT: a retrospective matched cohort study.
Huang M; Lin Q; Wang H; Chen J; Bai M; Wang L; Zhu K; Jiang Z; Guan S; Li Z; Qian J; Li M; Pang P; Shan H
Eur Radiol; 2016 Oct; 26(10):3428-36. PubMed ID: 26792430
[TBL] [Abstract][Full Text] [Related]
28. Transcatheter Arterial Chemoembolization Combined with Simultaneous Computed Tomography-guided Radiofrequency Ablation for Large Hepatocellular Carcinomas.
Zuo TY; Liu FY; Wang MQ; Chen XX
Chin Med J (Engl); 2017 Nov; 130(22):2666-2673. PubMed ID: 29133753
[TBL] [Abstract][Full Text] [Related]
29. [Single center experience over a 5-year period with sequential transarterial chemoembolization (TACE) in the treatment of hepatocellular carcinoma (HCC)].
Herber SC; Otto G; Woerns M; Moench C; Kanzler S; Junginger T; Schneider J; Schuchmann M; Kummer I; Manzl N; Düber C; Pitton MB
Rofo; 2007 Mar; 179(3):289-99. PubMed ID: 17325996
[TBL] [Abstract][Full Text] [Related]
30. Serial serum VEGF-A, angiopoietin-2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization.
Hsieh MY; Lin ZY; Chuang WL
Kaohsiung J Med Sci; 2011 Aug; 27(8):314-22. PubMed ID: 21802642
[TBL] [Abstract][Full Text] [Related]
31. Long-term outcome of transcatheter arterial chemoembolization after radiofrequency ablation as a combined therapy for Chinese patients with hepatocellular carcinoma.
Xu RC; Liu HC; Li JL; Li K; Ou SY; Yu ZY; Kong Y; Ma GA; Shao WS
Curr Med Res Opin; 2015 Aug; 31(8):1553-60. PubMed ID: 26067770
[TBL] [Abstract][Full Text] [Related]
32. Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis.
Kim JH; Yoon HK; Kim SY; Kim KM; Ko GY; Gwon DI; Sung KB
Aliment Pharmacol Ther; 2009 Jun; 29(12):1291-8. PubMed ID: 19392861
[TBL] [Abstract][Full Text] [Related]
33. Preservation of quality of life with doxorubicin drug-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma: Longitudinal prospective study.
Xing M; Webber G; Prajapati HJ; Chen Z; El-Rayes B; Spivey JR; Pillai AA; Kim HS
J Gastroenterol Hepatol; 2015 Jul; 30(7):1167-74. PubMed ID: 25675849
[TBL] [Abstract][Full Text] [Related]
34. Patterns of sorafenib and TACE treatment of unresectable hepatocellular carcinoma in a Chinese population: subgroup analysis of the GIDEON study.
Liu F; Meng Z; Shao G; Wang J; Wang Z; Yang J; Yip CS; He D
Mol Biol Rep; 2017 Feb; 44(1):149-158. PubMed ID: 27981445
[TBL] [Abstract][Full Text] [Related]
35. Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): a randomized controlled trial.
Chen LC; Chiou WY; Lin HY; Lee MS; Lo YC; Huang LW; Chang CM; Hung TH; Lin CW; Tseng KC; Liu DW; Hsu FC; Hung SK
BMC Cancer; 2019 Mar; 19(1):275. PubMed ID: 30922261
[TBL] [Abstract][Full Text] [Related]
36. Palliative treatment of unresectable hepatocellular carcinoma with obstructive jaundice using biliary drainage with subsequent transarterial chemoembolization.
Choi J; Ryu JK; Lee SH; Hwang JH; Ahn DW; Kim YT; Yoon YB; Yoon CJ; Kang SG; Chung JW
J Palliat Med; 2013 Sep; 16(9):1026-33. PubMed ID: 23888306
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Triple-Drug Transcatheter Arterial Chemoembolization (TACE) With Single-Drug TACE Using Doxorubicin-Eluting Beads: Long-Term Survival in 313 Patients.
Gomes AS; Monteleone PA; Sayre JW; Finn RS; Sadeghi S; Tong MJ; Britten CD; Busuttil RW
AJR Am J Roentgenol; 2017 Oct; 209(4):722-732. PubMed ID: 28705059
[TBL] [Abstract][Full Text] [Related]
38. A comparison of chemoembolization with conventional chemotherapy and symptomatic treatment in cirrhotic patients with hepatocellular carcinoma.
Bayraktar Y; Balkanci F; Kayhan B; Uzunalimoglu B; Gokoz A; Ozisik Y; Gurakar A; Van Thiel DH; Firat D
Hepatogastroenterology; 1996; 43(9):681-7. PubMed ID: 8799415
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of transcatheter arterial chemoembolization with embospheres in treatment of hepatocellular carcinoma.
Hao MZ; Lin HL; Chen QZ; Hu YB; Chen JB; Zheng JX; Zhou D; Zhang H
J Dig Dis; 2017 Jan; 18(1):31-39. PubMed ID: 27987344
[TBL] [Abstract][Full Text] [Related]
40. Comparison of health-related quality of life after transarterial chemoembolization and transarterial radioembolization in patients with unresectable hepatocellular carcinoma.
Kirchner T; Marquardt S; Werncke T; Kirstein MM; Brunkhorst T; Wacker F; Vogel A; Rodt T
Abdom Radiol (NY); 2019 Apr; 44(4):1554-1561. PubMed ID: 30311050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
